NCT07578194

Brief Summary

Coercive control (CC) is increasingly recognized as a central component of intimate partner violence (IPV) and a major determinant of victims' health outcomes. While widely integrated into policy and legal frameworks in several countries, CC remains insufficiently explored in the French research context, particularly regarding its clinical and psychopathological dimensions. This gap may limit the identification of victims and the provision of appropriate care. The present study aims to investigate the association between exposure to coercive control and physical and mental health outcomes among victims of intimate partner violence. By improving the understanding of CC-related health impacts, this research seeks to support better identification of high-risk situations and inform clinical and public health interventions.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
24mo left

Started May 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 5, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 11, 2026

Completed
19 days until next milestone

Study Start

First participant enrolled

May 30, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2028

Last Updated

May 11, 2026

Status Verified

May 1, 2026

Enrollment Period

2 years

First QC Date

May 5, 2026

Last Update Submit

May 5, 2026

Conditions

Coercive Control

Keywords

partner violence

Outcome Measures

Primary Outcomes (1)

  • Coercive Control Screening Scale

    Measure of Coercive Control Screening Scale (CCSS)

    Measure of CCSS between inlusion and month 6

Secondary Outcomes (8)

  • Measure of Hospital Anxiety and Depression scale (HAD scale)

    Measure of HHAD scale between inclusion and month 6

  • Severity of post-traumatic stress disorder symptoms

    at inclusion and month 6

  • International Trauma Questionnaire (ITQ)

    Inclusion and month 6

  • Severity of emotional dysregulation

    inclusion and month 6

  • Short Form Health Survey (SF-12)

    inclusion and month 6

  • +3 more secondary outcomes

Study Arms (1)

single arm

EXPERIMENTAL

Participants will complete online questionnaires via the Qualtrics platform

Other: questionnaire

Interventions

questionnaireOTHER

Participants will complete online questionnaires via the Qualtrics platform at baseline and at 6 months post-enrollment

single arm

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged 18 years and older, who have experienced an intimate partner relationship involving violence for at least three months (currently in the relationship or separated).
  • Women identified as victims of intimate partner violence.
  • Sufficient proficiency in French to complete self-administered questionnaires and participate in interviews.
  • No objection to participation in the study (non-opposition).
  • Affiliation with a French social security scheme or eligibility for universal health coverage (Couverture Maladie Universelle, CMU).

You may not qualify if:

  • Individuals under legal protection in accordance with the French Public Health Code (Articles L.1121-5 to L.1121-8 and L.1122-1-2), with the exception of pregnant or breastfeeding women.
  • Cognitive impairment or severe intellectual disability preventing comprehension of the questionnaires.
  • Severe and unstable psychiatric disorders (e.g., schizophrenia, delusional disorders, acute bipolar disorder).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHI Robert Ballanger

Aulnay-sous-Bois, Île-de-France Region, 93600, France

Location

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • fatima F Le Griguer, psychologist

    CHI Robert Balanger of GHT GPNE

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fatima F LE GRIGUER, Principal Investigator

CONTACT

00 33 1 49 36 72 38fatima.le-griguer@ght-gpne.fr

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2026

First Posted

May 11, 2026

Study Start (Estimated)

May 30, 2026

Primary Completion (Estimated)

May 30, 2028

Study Completion (Estimated)

May 30, 2028

Last Updated

May 11, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)